Report Detail

Pharma & Healthcare Global Gene Therapy Products Market Outlook 2021

  • RnM4274769
  • |
  • 30 December, 2020
  • |
  • Global
  • |
  • 90 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

1 Gene Therapy Products Market Overview

  • 1.1 Product Overview and Scope of Gene Therapy Products
  • 1.2 Gene Therapy Products Segment by Type
    • 1.2.1 Global Gene Therapy Products Sales Growth Rate Comparison by Type (2020-2026)
    • 1.2.2 Ex vivo
    • 1.2.3 In Vivo
  • 1.3 Gene Therapy Products Segment by Application
    • 1.3.1 Gene Therapy Products Sales Comparison by Application: (2020-2026)
    • 1.3.2 Cancer
    • 1.3.3 Monogenic
    • 1.3.4 Infectious disease
    • 1.3.5 Cardiovascular disease
    • 1.3.6 Other
  • 1.4 Global Gene Therapy Products Market Size Estimates and Forecasts
    • 1.4.1 Global Gene Therapy Products Revenue 2015-2026
    • 1.4.2 Global Gene Therapy Products Sales 2015-2026
    • 1.4.3 Gene Therapy Products Market Size by Region: 2020 Versus 2026

2 Global Gene Therapy Products Market Competition by Manufacturers

  • 2.1 Global Gene Therapy Products Sales Market Share by Manufacturers (2015-2020)
  • 2.2 Global Gene Therapy Products Revenue Share by Manufacturers (2015-2020)
  • 2.3 Global Gene Therapy Products Average Price by Manufacturers (2015-2020)
  • 2.4 Manufacturers Gene Therapy Products Manufacturing Sites, Area Served, Product Type
  • 2.5 Gene Therapy Products Market Competitive Situation and Trends
    • 2.5.1 Gene Therapy Products Market Concentration Rate
    • 2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
    • 2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
  • 2.7 Primary Interviews with Key Gene Therapy Products Players (Opinion Leaders)

3 Gene Therapy Products Retrospective Market Scenario by Region

  • 3.1 Global Gene Therapy Products Retrospective Market Scenario in Sales by Region: 2015-2020
  • 3.2 Global Gene Therapy Products Retrospective Market Scenario in Revenue by Region: 2015-2020
  • 3.3 North America Gene Therapy Products Market Facts & Figures by Country
    • 3.3.1 North America Gene Therapy Products Sales by Country
    • 3.3.2 North America Gene Therapy Products Sales by Country
    • 3.3.3 U.S.
    • 3.3.4 Canada
  • 3.4 Europe Gene Therapy Products Market Facts & Figures by Country
    • 3.4.1 Europe Gene Therapy Products Sales by Country
    • 3.4.2 Europe Gene Therapy Products Sales by Country
    • 3.4.3 Germany
    • 3.4.4 France
    • 3.4.5 U.K.
    • 3.4.6 Italy
    • 3.4.7 Russia
  • 3.5 Asia Pacific Gene Therapy Products Market Facts & Figures by Region
    • 3.5.1 Asia Pacific Gene Therapy Products Sales by Region
    • 3.5.2 Asia Pacific Gene Therapy Products Sales by Region
    • 3.5.3 China
    • 3.5.4 Japan
    • 3.5.5 South Korea
    • 3.5.6 India
    • 3.5.7 Australia
    • 3.5.8 Taiwan
    • 3.5.9 Indonesia
    • 3.5.10 Thailand
    • 3.5.11 Malaysia
    • 3.5.12 Philippines
    • 3.5.13 Vietnam
  • 3.6 Latin America Gene Therapy Products Market Facts & Figures by Country
    • 3.6.1 Latin America Gene Therapy Products Sales by Country
    • 3.6.2 Latin America Gene Therapy Products Sales by Country
    • 3.6.3 Mexico
    • 3.6.4 Brazil
    • 3.6.5 Argentina
  • 3.7 Middle East and Africa Gene Therapy Products Market Facts & Figures by Country
    • 3.7.1 Middle East and Africa Gene Therapy Products Sales by Country
    • 3.7.2 Middle East and Africa Gene Therapy Products Sales by Country
    • 3.7.3 Turkey
    • 3.7.4 Saudi Arabia
    • 3.7.5 U.A.E

4 Global Gene Therapy Products Historic Market Analysis by Type

  • 4.1 Global Gene Therapy Products Sales Market Share by Type (2015-2020)
  • 4.2 Global Gene Therapy Products Revenue Market Share by Type (2015-2020)
  • 4.3 Global Gene Therapy Products Price Market Share by Type (2015-2020)
  • 4.4 Global Gene Therapy Products Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Global Gene Therapy Products Historic Market Analysis by Application

  • 5.1 Global Gene Therapy Products Sales Market Share by Application (2015-2020)
  • 5.2 Global Gene Therapy Products Revenue Market Share by Application (2015-2020)
  • 5.3 Global Gene Therapy Products Price by Application (2015-2020)

6 Company Profiles and Key Figures in Gene Therapy Products Business

  • 6.1 Bluebird Bio
    • 6.1.1 Corporation Information
    • 6.1.2 Bluebird Bio Description, Business Overview
    • 6.1.3 Bluebird Bio Gene Therapy Products Sales, Revenue and Gross Margin (2015-2020)
    • 6.1.4 Bluebird Bio Products Offered
    • 6.1.5 Bluebird Bio Recent Development
  • 6.2 Sangamo
    • 6.2.1 Sangamo Corporation Information
    • 6.2.2 Sangamo Description, Business Overview
    • 6.2.3 Sangamo Gene Therapy Products Sales, Revenue and Gross Margin (2015-2020)
    • 6.2.4 Sangamo Products Offered
    • 6.2.5 Sangamo Recent Development
  • 6.3 Spark Therapeutics
    • 6.3.1 Spark Therapeutics Corporation Information
    • 6.3.2 Spark Therapeutics Description, Business Overview
    • 6.3.3 Spark Therapeutics Gene Therapy Products Sales, Revenue and Gross Margin (2015-2020)
    • 6.3.4 Spark Therapeutics Products Offered
    • 6.3.5 Spark Therapeutics Recent Development
  • 6.4 Dimension Therapeutics
    • 6.4.1 Dimension Therapeutics Corporation Information
    • 6.4.2 Dimension Therapeutics Description, Business Overview
    • 6.4.3 Dimension Therapeutics Gene Therapy Products Sales, Revenue and Gross Margin (2015-2020)
    • 6.4.4 Dimension Therapeutics Products Offered
    • 6.4.5 Dimension Therapeutics Recent Development
  • 6.5 Avalanche Bio
    • 6.5.1 Avalanche Bio Corporation Information
    • 6.5.2 Avalanche Bio Description, Business Overview
    • 6.5.3 Avalanche Bio Gene Therapy Products Sales, Revenue and Gross Margin (2015-2020)
    • 6.5.4 Avalanche Bio Products Offered
    • 6.5.5 Avalanche Bio Recent Development
  • 6.6 Celladon
    • 6.6.1 Celladon Corporation Information
    • 6.6.2 Celladon Description, Business Overview
    • 6.6.3 Celladon Gene Therapy Products Sales, Revenue and Gross Margin (2015-2020)
    • 6.6.4 Celladon Products Offered
    • 6.6.5 Celladon Recent Development
  • 6.7 Vical Inc.
    • 6.6.1 Vical Inc. Corporation Information
    • 6.6.2 Vical Inc. Description, Business Overview
    • 6.6.3 Vical Inc. Gene Therapy Products Sales, Revenue and Gross Margin (2015-2020)
    • 6.4.4 Vical Inc. Products Offered
    • 6.7.5 Vical Inc. Recent Development
  • 6.8 Advantagene
    • 6.8.1 Advantagene Corporation Information
    • 6.8.2 Advantagene Description, Business Overview
    • 6.8.3 Advantagene Gene Therapy Products Sales, Revenue and Gross Margin (2015-2020)
    • 6.8.4 Advantagene Products Offered
    • 6.8.5 Advantagene Recent Development

7 Gene Therapy Products Manufacturing Cost Analysis

  • 7.1 Gene Therapy Products Key Raw Materials Analysis
    • 7.1.1 Key Raw Materials
    • 7.1.2 Key Raw Materials Price Trend
    • 7.1.3 Key Suppliers of Raw Materials
  • 7.2 Proportion of Manufacturing Cost Structure
  • 7.3 Manufacturing Process Analysis of Gene Therapy Products
  • 7.4 Gene Therapy Products Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

  • 8.1 Marketing Channel
  • 8.2 Gene Therapy Products Distributors List
  • 8.3 Gene Therapy Products Customers

9 Market Dynamics

  • 9.1 Market Trends
  • 9.2 Opportunities and Drivers
  • 9.3 Challenges
  • 9.4 Porter's Five Forces Analysis

10 Global Market Forecast

  • 10.1 Global Gene Therapy Products Market Estimates and Projections by Type
    • 10.1.1 Global Forecasted Sales of Gene Therapy Products by Type (2021-2026)
    • 10.1.2 Global Forecasted Revenue of Gene Therapy Products by Type (2021-2026)
  • 10.2 Gene Therapy Products Market Estimates and Projections by Application
    • 10.2.1 Global Forecasted Sales of Gene Therapy Products by Application (2021-2026)
    • 10.2.2 Global Forecasted Revenue of Gene Therapy Products by Application (2021-2026)
  • 10.3 Gene Therapy Products Market Estimates and Projections by Region
    • 10.3.1 Global Forecasted Sales of Gene Therapy Products by Region (2021-2026)
    • 10.3.2 Global Forecasted Revenue of Gene Therapy Products by Region (2021-2026)

11 Research Finding and Conclusion

    12 Methodology and Data Source

    • 12.1 Methodology/Research Approach
      • 12.1.1 Research Programs/Design
      • 12.1.2 Market Size Estimation
      • 12.1.3 Market Breakdown and Data Triangulation
    • 12.2 Data Source
      • 12.2.1 Secondary Sources
      • 12.2.2 Primary Sources
    • 12.3 Author List

    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

    Segment by Type, the Gene Therapy Products market is segmented into
    Ex vivo
    In Vivo

    Segment by Application
    Cancer
    Monogenic
    Infectious disease
    Cardiovascular disease
    Other

    Global Gene Therapy Products Market: Regional Analysis
    The Gene Therapy Products market is analysed and market size information is provided by regions (countries). The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type and by Application segment in terms of sales and revenue for the period 2015-2026.
    The key regions covered in the Gene Therapy Products market report are:
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Philippines
    Vietnam
    Latin America
    Mexico
    Brazil
    Argentina
    Middle East & Africa
    Turkey
    Saudi Arabia
    U.A.E

    Global Gene Therapy Products Market: Competitive Analysis
    This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.

    The major players in global Gene Therapy Products market include:
    Bluebird Bio
    Sangamo
    Spark Therapeutics
    Dimension Therapeutics
    Avalanche Bio
    Celladon
    Vical Inc.
    Advantagene


    Summary:
    Get latest Market Research Reports on Gene Therapy Products. Industry analysis & Market Report on Gene Therapy Products is a syndicated market report, published as Global Gene Therapy Products Market Outlook 2021. It is complete Research Study and Industry Analysis of Gene Therapy Products market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $2,900.00
    $4,350.00
    $5,800.00
    2,118.22
    3,177.33
    4,236.44
    2,381.46
    3,572.19
    4,762.93
    300,866.30
    451,299.45
    601,732.60
    211,722.62
    317,583.93
    423,445.24
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report